지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2024.5
- 수록면
- 210 - 221 (12page)
- DOI
- 10.3343/alm.2023.0388
이용수
초록· 키워드
오류제보하기
Chimeric antigen receptor (CAR) T-cell therapy is a promising immunotherapy based on genetically engineered T cells derived from patients. The introduction of CAR T-cell therapy has changed the treatment paradigm of patients with B-cell lymphoid malignancies. However, challenging issues including managing life-threatening toxicities related to CAR T-cell infusion and resistance to CAR T-cell therapy, leading to progression or relapse, remain. This review summarizes the issues with currently approved CAR T-cell therapies for patients with relapsed or refractory B-cell lymphoid malignancies, including lymphoma and myeloma. We focus on unique toxicities after CAR T-cell therapy, such as cytokine-related events and hematological toxicities, and the mechanisms underlying post-CAR T-cell failure.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
CAR-T 세포 치료제
대한내과학회지
2022 .08
-
Practical issues in CAR T-cell therapy
Blood Research
2023 .04
-
광범위큰B세포림프종에 대한 키메릭항원수용체T세포 (Chimeric Antigen Receptor T-cells) 치료
대한내과학회지
2019 .04
-
Management of adverse events in young adults and children with acute B-cell lymphoblastic leukemia receiving anti-CD19 chimeric antigen receptor (CAR) T-cell therapy
Blood Research
2023 .04
-
CAR T Cell Immunotherapy Beyond Haematological Malignancy
Immune Network
2022 .02
-
Chimeric Antigen Receptor T Cell Therapy: A Novel Modality for Immune Modulation
전남의대학술지
2020 .01
-
Current and future perspectives on CAR-T cell therapy for renal cell carcinoma: A comprehensive review
Investigative and Clinical Urology
2022 .09
-
Research on Epstein-Barr virus immunity using a mouse model: from new insights to cancer immunotherapeutic applications
한국실험동물학회 학술발표대회 논문집
2022 .01
-
Evolution of CAR-T Cell Therapy
대한외과학회 학술대회 초록집
2019 .10
-
Manufacturing Cell and Gene Therapies: Challenges in Clinical Translation
Annals of Laboratory Medicine
2024 .07
-
A general view of CD33+ leukemic stem cells and CAR-T cells as interesting targets in acute myeloblatsic leukemia therapy
Blood Research
2020 .01
-
Engineering Cell Therapies for Autoimmune Diseases: From Preclinical to Clinical Proof of Concept
Immune Network
2022 .10
-
The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future
Clinical and Molecular Hepatology
2021 .01
-
Monovalent Anti-CD3 Antibodies Effectively Eliminate the TCR-Positive Fraction of TCR-Deleted Allogeneic CAR-T Cells to Prevent GVHD
Immune Network
2024 .12
-
Clonal Expansion of Allergen-specific CD4+ T Cell in the Lung in the Absence of Lymph Nodes
Immune Network
2017 .06
-
Immune Correlates of Resistance to Trichinella spiralis Reinfection in Mice
Parasites, Hosts and Diseases
2016 .10
-
Delayed Terminal Ileal Perforation in a Relapsed/Refractory B-Cell Lymphoma Patient with Rapid Remission Following Chimeric Antigen Receptor T-Cell Therapy
Cancer Research and Treatment
2018 .01
-
Outcomes of Anti-CD19 CAR-T Treatment of Pediatric B-ALL with Bone Marrow and Extramedullary Relapse
Cancer Research and Treatment
2022 .07
-
Metabolic Challenges in Anticancer CD8 T Cell Functions
Immune Network
2023 .02
-
장기이식 거부반응과 자가면역질환 치료제로서의 CAR Treg 세포치료제의 가능성: Treg 세포치료제 임상시험 현황과 CAR T 세포치료제 허가 정보를 바탕으로
Clinical Transplantation and Research
2017 .01
최근 본 자료
댓글(0)
0